Nationality: Chinese Female
Age- 27 by the time of matriculation in 2022 or 28 by the time of matriculation in 2023
GMAT- Not taken but aiming for 730. Took GRE when I applied to grad school in 2017 (167 Q, 159 V)
Undergrad - BSc in Biomedical Sciences (First Class Honors - WES Evaluated 3.94/4.00)
Grad - Top MPH Program in Health Policy and Management in the U.S.
Work Experience - 2 years by Fall 2022 or 3 year by Fall 2023
Company -
Full time
Consulting Firm Focused on Life Sciences (Shanghai Office) - Joined Summer of 2020
Internship at a Tier 2 Consulting Firm's Healthcare Practice in Chicago
Internship at Boutique Life Sciences Consulting Firm in London
Professional Experience (<1 Year So Far)
- Market Access Evaluation for American pharma company
- Collaborated closely with the U.S. Office
- Conducted expert interviews with Chinese doctors
- Built models to estimate the size of the China market for a drug
- Completed the project solo when senior analyst left due to health reason
- Market Access Evaluation for American pharma company 2.0
- Similar work to first evaluation but involves a lot more upward management since I was able to handle it solo for my first project
- Market Access Evaluation for Local Pharma Company
- In progress.. Similarly a lot of upwards management.
- Proposal writing for projects
Extra-curriculars
- Something that I am weaker at right now. Pretty much non-existent due to my very demanding job. I would like to understand what I can do to boost my chances
Post-MBA Objective:
- Life Science/Healthcare consulting in Top tier or Boutique Firm in the U.S
Schools:
Preference: Top 15
Question:
- What are my chances at schools if I apply for the upcoming cycle and what are my chances if I waited for an additional year? My main goal is to use an MBA to continue my consulting career in the U.S (ideally at the next level). Are there other options besides an MBA?